Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BOEUF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2026 98.56M
December 31, 2025 94.08M
September 30, 2025 88.88M
June 30, 2025 83.60M
March 31, 2025 73.75M
December 31, 2024 65.84M
September 30, 2024 65.29M
June 30, 2024 59.43M
March 31, 2024 53.72M
December 31, 2023 54.10M
September 30, 2023 48.75M
June 30, 2023 26.14M
March 31, 2023 26.25M
December 31, 2022 25.81M
September 30, 2022 25.54M
June 30, 2022 23.45M
March 31, 2022 27.10M
December 31, 2021 29.35M
September 30, 2021 32.57M
June 30, 2021 42.06M
March 31, 2021 43.60M
Date Value
December 31, 2020 48.57M
September 30, 2020 47.50M
June 30, 2020 47.45M
March 31, 2020 10.41M
December 31, 2019 13.28M
September 30, 2019 16.32M
June 30, 2019 20.75M
March 31, 2019 25.87M
December 31, 2018 31.42M
September 30, 2018 36.40M
June 30, 2018 42.61M
March 31, 2018 49.76M
December 31, 2017 55.06M
September 30, 2017 61.22M
June 30, 2017 55.11M
March 31, 2017 1.019M
December 31, 2016 3.776M
September 30, 2016 -5.041M
June 30, 2016 -1.501M
March 31, 2016 0.7928M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
BioInvent International AB 46.09M
Hansa Biopharma AB -28.90M
BioArctic AB 230.74M
Swedish Orphan Biovitrum AB 4.238B
Diamyd Medical AB 18.82M

Shareholders Equity (Quarterly) Related Metrics